Skip to main content
Clinical Trials/CTRI/2025/09/095469
CTRI/2025/09/095469
Not yet recruiting
Phase 4

Comparing the efficacy of mouthwash enriched with pomegranate extract versus chlorhexidine mouthwash in the control of plaque and gingivits

Dr Manika Rawat1 site in 1 country20 target enrollmentStarted: October 14, 2025Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Dr Manika Rawat
Enrollment
20
Locations
1
Primary Endpoint
Gingival health will be assessed using Loe and Silness gingival index and plaque scores which will be assessed using Turesky-Gilmore modification of Quingley hein plaque index

Overview

Brief Summary

This study is a  randomized double blinded clinical trial to compare the efficacy of a pomegranate peel extract mouthwash with chlorhexidine in managing plaque and gingivitis among 20 patients aged between 18 to 40 years with mild to moderate gingivitis. Participants will be assigned to either the pomegranate group or the chlorhexidine group and will be instructed to rinse twice daily for 21 days. Clinical parameters including Plaque Index and Gingival Index will be assessed at baseline 14 days and 21 days. Findings from this study will help determine whether pomegranate which is a natural agent with antimicrobial and anti-inflammatory properties can serve as a safe and effective alternative to chlorhexidine which despite its efficacy is associated with side effects such as tooth staining and altered taste.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 40.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Systematically healthy voluntary participants Participants with mild to moderate gingivitis With atleast 20 natural teeth present in the mouth Participants who are willing to comply with appointment schedule.

Exclusion Criteria

  • Participants with any systematic disease Undergoing orthodontic treatment Pregnant and nursing females With positive history of antibiotic, corticosteroid or periodontal therapy in past one month Using antimicrobial mouthwashes Smokers Who refuse to participate in the study.

Outcomes

Primary Outcomes

Gingival health will be assessed using Loe and Silness gingival index and plaque scores which will be assessed using Turesky-Gilmore modification of Quingley hein plaque index

Time Frame: Data will be recorded at the baseline, 14 days and 21 days

Secondary Outcomes

  • Any adverse or unintended effects of mouthwash will be taken as secondary outcome(14 days and 21 days)

Investigators

Sponsor
Dr Manika Rawat
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Manika Rawat

Teerthanker Mahaveer Dental College and Research Centre

Study Sites (1)

Loading locations...

Similar Trials